Immunomedics Attys Win $12M Fee In $40M Data Scandal Deal
Attorneys who represented a proposed class of investors in pharmaceutical company Immunomedics Inc. will receive nearly $12 million as their fee....To view the full article, register now.
Already a subscriber? Click here to view full article